tirzepatide for heart health UC Irvine researchers project cardiac benefits from weight-loss medication Tirzepatide cuts heart failure risk

The findings provide reassurance on several fronts

It's not just about eating too much

Your BMI must exceed 30, or exceed 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea

At equivalent time points, tirzepatide typically produces 1525% greater weight loss than semaglutide, translating to roughly 45 months versus 57 months for 30-pound milestones

[7] [1] As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Zepbound works by mimicking natural hormones that regulate appetite, food intake, and blood sugar levels

Recognizing the early signs is critical because timely management can prevent a worsening condition